We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

mAbs: Anti-infectives

Find out how to publish your research
in the high-impact journal of antibody development

At mAbs, we are looking for research on anti-infectives, an emerging topic of considerable interest to the journal and its readership. Explore this collection of highly-cited research and find out how you can contribute your research to this Q1 ranked journal.

Anti-Infectives Research
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
Pengfei Fan, Xiangyang Chi, Guodong Liu, Guanying Zhang, Zhengshan Chen, Yujiao Liu, Ting Fang, Jianmin Li, Logan Banadyga, Shihua He, Changming Yu, Xiangguo Qiu & Wei Chen
mAbs, Volume 12, 2020 – Issue 1

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
Marco Tuccori, Sara Ferraro, Irma Convertino, Emiliano Cappello, Giulia Valdiserra, Corrado Blandizzi, Fabrizio Maggi & Daniele Focosi
mAbs, Volume 2020 – Issue 1


Protective antibodies against human parainfluenza virus type 3 infection
Jim Boonyaratanakornkit, Suruchi Singh, Connor Weidle, Justas Rodarte, Ramasamy Bakthavatsalam, Jonathan Perkins, Guillaume B.E. Stewart-Jones, Peter D. Kwong, Andrew T. McGuire, Marie Pancera & Justin J. Taylor
mAbs, Volume 12, 2021 – Issue 1


David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors
Mohamed A. Alfaleh, Ayat Zawawi, Sawsan S. Al-Amri & Anwar M. Hashem
mAbs, Volume 14, 2022 – Issue 1

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
Maxwell A. Stefan, Yooli K. Light, Jennifer L. Schwedler, Peter R. McIlroy, Colleen M. Courtney, Edwin A. Saada, Christine E. Thatcher, Ashlee M. Phillips, Feliza A. Bourguet, Catherine M. Mageeney, Summer A. McCloy, Nicole M. Collette, Oscar A. Negrete, Joseph S. Schoeniger, Dina R. Weilhammer & Brooke Harmon
mAbs, Volume 13, 2021 – Issue 1

Become a published author in mAbs

  • Maximised discoverability of your research: 970k annual downloads/views

  • High-Impact Journal: Ranked #35 out of 140 journals for Medicine, Research & Experimental

  • Timely publication of your article: 14 days avg. from submission to first decision; 27 days avg. from submission to first post-review decision; 27 days avg. from acceptance to online publication

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.